Continuity Biosciences Welcomes Josephine Torrente and Joseph DeSimone to Its Board of Directors Continuity Biosciences has announced the appointment of Josephine Torrente and Dr. Joseph DeSimone to its board, marking a significant step forward.

Continuity Biosciences Welcomes Josephine Torrente and Joseph DeSimone to Its Board of Directors #USA #Bradenton #Continuity_Biosciences #Josephine_Torrente #Joseph_DeSimone

Continuity Biosciences Names New Board Members to Enhance Drug Delivery Innovations Continuity Biosciences has appointed Josephine Torrente and Joseph DeSimone, PhD, to its board, enhancing the company's drug delivery technology efforts with their expertise.

Continuity Biosciences Names New Board Members to Enhance Drug Delivery Innovations #USA #Bradenton,_Florida #Continuity_Biosciences #Josephine_Torrente #Joseph_DeSimone

Continuity Biosciences Strengthens Board with New Additions to Fuel Innovation in Drug Delivery Continuity Biosciences has appointed Josephine Torrente and Dr. Joseph DeSimone to its Board, enhancing its expertise in drug delivery and regulatory strategy.

Continuity Biosciences Strengthens Board with New Additions to Fuel Innovation in Drug Delivery #USA #Bradenton #Continuity_Biosciences #Josephine_Torrente #Joseph_DeSimone